Moreover, the potential of BOK circRNAs as diagnostic and prognostic molecular biomarkers could be elucidated in the future by assessing their expression in ovarian and prostate cancer patients’ tissue samples. The gene discussed is BOK; the disease is Familial prostate cancer.